EHVA – EUROPEAN HIV VACCINE ALLIANCE, AN EU PLATFORM FOR THE DISCOVERY AND EVALUATION OF NOVEL PROPHYLACTIC AND THERAPEUTIC VACCINE CANDIDATES
Project aims: To develop a Multidisciplinary Vaccine Platform (MVP) in the fields of prophylactic and therapeutic HIV vaccines. The MVP includes four components: 1) Discovery, 2) Immune Profiling, 3) Data Management, Integration and Down-Selection, and 4) Clinical Trials.
Project leader: Institut national de la santé et de la recherche médicale (INSERM)
Main partners: Involves 39 institutions including Universities, Research Institutes, SMEs and larger industries.
EATG participation: Involved in WP 9: Therapeutic Vaccine Trials; WP 11: Dissemination and Exploitation. EATG is community partner in this project ensuring community feedback to the scientific developments within the project.
Duration: January 2016 – January 2021
Main funding source/programme: EC Horizon 2020
Budget: 50,000 EUR
EATG contact person(s): Giorgio Barbareschi (office) at email@example.com and Mariana Vicente (office) at firstname.lastname@example.org; Giulio M Corbelli (EATG membership) at email@example.com